Otsuka Holdings Co Ltd (4578) Stock Price & News

4578:TYO

Otsuka Holdings Co Ltd

¥11,705.00

+0.34%

(+40.00) 1D

Oct 13, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 4578...

Open

¥11,665

High

¥11,760

Low

¥11,525

Mkt. cap

6.36T

Avg. vol.

1.29M

Volume

1.03M

Dividend

1.45%

Quarterly dividend

¥43

Ex-dividend date

Dec 29, 2026

P/E ratio

15.24

52-wk high

¥12,795

52-wk low

¥7,756

EPS

¥768

Shares outstanding

541.85M

No. of employees

38K

Open

¥11,665

High

¥11,760

Low

¥11,525

Mkt. cap

6.36T

Avg. vol.

1.29M

Volume

1.03M

Dividend

1.45%

Quarterly dividend

¥43

Ex-dividend date

Dec 29, 2026

P/E ratio

15.24

52-wk high

¥12,795

52-wk low

¥7,756

EPS

¥768

Shares outstanding

541.85M

No. of employees

38K

Related stocks

4519

Chugai Pharmaceutical Co Ltd

Daiichi Sankyo Co Ltd

¥2,636.00

+0.50%

4502

Takeda Pharmaceutical Co Ltd

¥5,963.00

+2.05%

News stories

From web sources and news partners

MarketForces Africa

48 minutes ago

European Stocks Rally As AI Bears Drag S&P 500, Nasdaq Lower

CNBC

32 minutes ago

S&P 500 futures are mixed ahead of bank earnings

TradingView

1 hour ago

Stock Market Today: Dow Jones, S&P 500 Futures Gain While Nasdaq 100 Falls as Scott Bessent Says Iran's Economy Is 'Collapsing' — SXTC, AMAT, CMG in Focus

Inc.com

2 hours ago

The S&P 500’s Bull Market Just Turned 4. History Says the Next Year Is What Matters Most

About Otsuka Holdings Co Ltd

CEO-

Employees37.8K

FoundedJul 8, 2008

Headquarters-

SectorPharmaceutical industry

Websiteotsuka.com

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	637.98B	650.15B	630.34B	702.05B
Cost of goods sold	180.95B	192.74B	174.09B	191.82B
Cost of revenue	180.95B	192.74B	174.09B	191.82B
Research and development expenses	85.74B	104.19B	82.10B	90.07B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	253.75B	279.91B	259.49B	274.44B
Operating expense	287.73B	431.74B	338.04B	366.05B
Total operating expenses	468.69B	624.47B	512.13B	557.87B
Operating income	169.29B	25.68B	118.21B	144.18B
Other non operating income	1.00M	3.94B	-4.00M	3.00M
EBT including unusual items	166.43B	75.26B	130.22B	155.20B
EBT excluding unusual items	180.64B	42.60B	130.51B	158.96B
Income tax expense	40.87B	10.48B	30.93B	35.95B
Effective tax rate	24.56%	13.92%	23.75%	23.16%
Other operating expenses	-51.76B	47.63B	-3.56B	1.54B
Net income	124.13B	65.49B	98.35B	117.26B
Net profit margin	19.46%	10.07%	15.60%	16.70%
Earnings per share	-	-	-	-
Interest and investment income	2.47B	20.58B	5.98B	5.65B
Interest expense	-1.34B	-358.00M	-2.04B	-2.72B
Net interest expenses	1.13B	20.23B	3.94B	2.94B
Depreciation and amortization charges	-	-	-	-
EBITDA	197.78B	58.20B	148.58B	175.28B
Gain or loss from assets sale	-	26.43B	-	4.05B

Finance

Ask anything